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doi:10.1016/j.asjsur.2012.04.013Summary Hypophysitis is a rare inflammatory disorder that can mimic a pituitary tumor clin-
ically or radiologically. Furthermore, immunoglobulin G4 (IgG4)-related systemic disease is
only a just recently characterized disorder. It can manifest as a systemic disease involving
multiple organs, including the pancreas, salivary glands, lungs, liver, bile duct, gallbladder,
kidneys, and retroperitoneum. It is characterized by a high serum level of IgG4 clinically
and dense lymphoplasmacytic infiltration with sclerosis and phlebitis histologically. Herein,
we report the case of a man 66 years of age who presented with nausea, vomiting, and poor
appetite with a body weight loss of 4 kg. Image study revealed a pituitary infundibulum mass,
right-posterior mediastinal and paraspinal masses, as well as infiltrating masses in bilateral
kidneys. Therefore, he received a thoracoscopic biopsy for the right-posterior mediastinal
and paraspinal masses and a pathologic examination reported an IgG4-related inflammatory
pseudotumor. Then, transsphenoidal removal of the infundibulum mass was performed. Histo-
logically, the infundibulum mass represented a IgG4-related hypophysitis manifested as an
infiltration of plasma cells, lymphocytes, histiocytes, and some eosinophils with a fair number
of IgG4-immunoreactive plasma cells. After the operation was complete, the patient took 5 mg
of prednisolone every 2 days for 3 months. A follow-up computed tomography scan revealed
improvement of the infiltrating masses in the bilateral kidneys.
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Immunoglobulin G4 (IgG4)-related sclerosing disease is
a recently identified entity. Pancreatic involvement is the
most common manifestation. However, other systemic
involvement has also been reported, including the hep-
atobiliary tract, salivary glands, orbit, lymph nodes, ret-
roperitoneum, aorta, mediastinum, soft tissue, skin, the
central nervous system, breasts, kidneys, prostate, upper
aerodigestive tract, and lungs.1,2 Hypophysitis is a rare
inflammatory disorder and IgG4-related sclerosing disease
involving the pituitary glands is especially rare.1 Imaging
studies may reveal a mass lesion in the sellar area or
a thickening of pituitary stalk, mimicking a pituitary tumor.
Clinically, most patients present with hypopituitarism,
diabetes insipidus, and/or a local mass effect. Serum IgG4
level is always elevated.3 Histopathologically, IgG4-related
sclerosing disease is characterized by dense lympho-
plasmacytic infiltration, stromal sclerosis, and the presence
of phlebitis.1 Immunohistochemical study can demonstrate
increased IgG4-positive plasma cells. In our current report,
we describe an elderly Chinese man diagnosed with IgG4-
related hypophysitis associated with multiple organ
involvement but who lacked pancreatitis. His clinical
manifestation improved dramatically after he received
steroid treatment.
2. Case report
A man aged 66 years presented with nausea, vomiting, poor
appetite, and body weight loss of 4 kilograms in 1 month.
He had a history of acute cholecystitis status post-
cholecystectomy and chronic hypertrophic rhinitis.
Anorexia and fatigue were also noted. His condition did not
improve after he asked help from the Show Chwan Memo-
rial Hospital Changhua, Taiwan and a postmediastinal mass
with diffuse mediastinal lymph node enlargement was
revealed by chest computed tomography (CT) scan. Then,
he was transferred to our hospital. Physical examination
revealed no specific findings. The chest CT scan demon-
strated a 2.4-cm nodule in the right middle lobe abutting
the right pericardial pleura and an infiltrating right-
posterior mediastinal and paraspinal masses with pleural
extension (Fig. 1A). No extension to bone or intraspinal
canals was noted. There were multiple mediastinal lymph
node enlargements, with the largest being a diameter of
about 17 mm in the aortopulmonary window (AP) window
region. In addition, bilateral infiltrating masses were noted
in the upper kidney level (Fig. 1B). The stomach also
demonstrated focal thickening of the wall over the lesser
curvature side.
The patient first received a thoracoscopic biopsy, and
a pathologic examination reported an inflammatory pseu-
dotumor, suggestive of IgG4-related sclerosing disease. After
thoracoscopic biopsy, his condition still did not improve and
laboratory tests revealed eosinophilia (7.9%), a low testos-
terone level (＜0.008 ng/ml; reference range, 1.66e8.11 ng/
ml) and primary hypoadrenalism with a low cortisol level
(0.65 mg/dl before 10 AM; reference range, 4.46e22.69 mg/dl)
and an elevated adrenocorticotropic hormone (ACTH) level
(56.1 pg/ml; reference range, ＜46 pg/ml), but otherpituitary hormones were within the normal range. The
brain magnetic resonance imaging (MRI) demonstrated
a 2.4-cm, well-defined mass in the sella turcica, showing
isointense on a T1- and T2-weighted image with strong
enhancement after injection of the contrast medium
(Fig. 2). No residual normal pituitary tissue of the
posterior lobe was noted. The mass lesion extended
upward and compressed the optic chiasm. Macroadenoma
was initially suspected. Then, he commenced glucocorti-
coid replacement therapy and received transsphenoidal
removal of the infundibulum mass.
After the operation, the patient kept taking 5 mg of
prednisolone every 2 days for 3 months and a follow-up CT
scan revealed a significant decrease in the size of the
previously noted nodule in right middle lobe, posterior
mediastinal and right paraspinal masses (Fig. 1C) and prior
infiltrating masses in both kidneys (Fig. 1D).
The received specimen of the thoracoscopic biopsy
consisted of one tissue fragment measuring
1.3  0.6  0.2 cm in size. Grossly, it was grayish and firm.
Microscopically, the fibrous tissue fragment showed bland-
appearing spindle cell proliferation in the fibrotic or scle-
rotic background with marked infiltration of lymphocytes,
plasma cells, as well as eosinophils and focal lymphoid
follicle formation (Fig. 3A). Focal vasculitis was also
present (Fig. 3B). Immunohistochemistry for the kand l
light chains showed no light chain restriction in these
plasma cells. The immunohistochemical study for IgG4
showed abundant positive plasma cells (more than 30 per
high power field (400) HPF). This is shown in Fig. 3C.
Seven tiny pieces of tan-soft tissue specimens,
measuring up to 0.2  0.1  0.1 cm in size, werereceived
for pathologic examination. Microscopic examination
revealed the specimen consisted mainly of neurohypophy-
sial tissue by lymphocytes, plasma cells, and eosinophils
with stromal edema and mild fibrosis (Fig. 4A). The reticulin
highlighted a fragment of adenohypophysial tissue.The
immunohistochemical study of the IgG4 stain highlighted
a fair number of IgG4 immunoreactive plasma cells
(Fig. 4B). Taken together, IgG4-related hypophysitis was
diagnosed.3. Discussion
In 1961, Sarles and colleagues1 first raised the concept that
some cases of chronic pancreatitis resulted from an auto-
immune etiology. In 1995, Yoshida and coworkers 4 intro-
duced the term “autoimmune pancreatitis (AIP)”,
characterized by mass lesions in the pancreas, narrowing of
the pancreatic duct, painless obstructive jaundice, and
favorable response to steroid therapy. In 2001, Hamano and
others5 first found elevated serum IgG4, increased IgG4-
positive plasma cells, and lymphoplasmacytic sclerosing
change in a specific subtype of sclerosing pancreatitis.
Then, a distinct subtype of AIP, named “IgG4-related scle-
rosing pancreatitis,” was designated. However, other sites
of involvement have subsequently also been noted,
including hepatobiliary tract, salivary glands, orbit, lymph
nodes, retroperitoneum, aorta, mediastinum, soft tissues,
lymph nodes, bone marrow, skin, the central nervous
system, breasts, kidneys, prostate, upper aerodigestive
Figure 1 (A) Infiltrating right posterior mediastinal and paraspinal masses with pleural extension; (B) bilateral infiltrating masses
in both kidneys; (C) after steroid treatment, there was a significant decrease in the size of the previously noted nodule in the
posterior mediastinal and right paraspinal masses, (D) as well as in the prior infiltrating masses in both kidneys.
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related systemic disease was proposed. IgG4-related scle-
rosing disease is defined as a systemic syndrome and
characterized by mass-forming lesions clinically. The
histologic triad includes lymphoplasmacytic infiltrates,
sclerosis, and obliterative phlebitis.1 There are numerous
IgG4-positive plasma cells in the affected tissues, and the
serum IgG4 level is also increased.3 Most IgG4-relatedFigure 2 Well-defined mass in the sella turcica with strong
enhancement after the injection of contrast medium.sclerosing diseases occur with AIP, but some lacking
pancreatic involvement have also been reported.6 These
diseases predominantly affect elderly men and, clinically,
such patients generally respond well to steroid treatment.
IgG4-related sclerosing disease involving the central
nervous system is very rare and the pituitary gland is the
most commonly reported site.1 To date, only 25 cases
(including the present case) have been reported.6e8 There
were 23 men and two women patients with an obvious male
predominance. The age of the patients ranged from 42e77
years of age with a mean age of 64.76 years. Most patients
presented with hypopituitarism, diabetes insipidus (DI),
and/or a local mass effect. Serum IgG4 were all elevated
during the active stage if checked. Most cases were asso-
ciated with other systemic involvement. Some cases had
concomitant pachymeningitis or parasinusitis with exten-
sion to sellar and parasellar structures.1,6 Only one patient
was manifested as an isolated pituitary lesion.6 Most
patients were diagnosed by clinical correlation and
imaging, while only six cases had been proven through
pathologic examination.
Imaging study often reveals a thickening or mass
formation on the pituitary stalk and the thickening may
occur up to the level of infundibulum. Sometimes, it may
present as a swelling of pituitary gland or a mass formation
in the pituitary gland.
The diagnostic criteria for IgG4-related sclerosing
disease is still a controversy issue since there are a variety
of diagnostic criteria for AIP that have been proposed by
different groups. In addition, an agreement has still not
been reached on the cut-off number of IgG4þ plasma cells.
A number greater than 30 per high-power field has been
reported to be reasonably specific,1 while Dhall and
Figure 3 (A) Bland-appearing spindle cell proliferation in a fibrotic or sclerotic background with infiltration of lymphocytes,
plasma cells, and focal lymphoid aggregates (40); (B) focal vasculitis is present (400); (C) abundant IgG4-positive plasma cells
(more than 30 per HPF) according to immunohistochemical study (400). HPF Z high power field (400); Ig Z immunoglobulin.
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of IgG4þ cells, numbering more than 50 per high-power
field, to be of high specificity. Afterward, Wah and
others1 proposed the histologic criteria of IgG4-related
sclerosing disease, including absolute number of IgG4þ
cells > 50/HPF, percentage of IgG4þ/IgGþ cells >40%, and
characteristic morphology, such as lymphoplasmacytic
infiltration  lymphoid follicles, sclerosis, and phlebitis.
The pathogenesis of IgG4-related sclerosing disease is
still under intense investigation.6 It has been believed that
autoimmune mechanism plays a role in this condition. First
of all, serum IgG as well as IgG4 levels are often elevated
and most patients show a good clinical response to corti-
costeroid treatment.2,6 It is also reported that possession ofFigure 4 (A) Specimen mainly consisting of neurohypophysial tis
edema and mild fibrosis (100); (B) a fair number of IgG4 immuno
(400). Ig Z immunoglobulin.a particular HLA genotype (HLA DRB1*0405- DQB1*0401) is
related to an increased risk of disease development.2,5
Besides, immune complex deposition has been identified
with tissue affected by IgG4-related systemic sclerosing
disease ultrastructurally.2,5 It is also known that disease
induction occurs due to the development of an immune
response to self-antigens and in association with a decrease
in naive regulatory T cells in peripheral blood and increased
infiltration of memory regulatory T cells in involved tissue.
Disease progression results from a switch to a T helper 2
(Th2) response with expression of Th2 cytokines and regu-
latory cytokines2,3,5; however, there are no precise triggers
identified for initiation to date. Furthermore, the role of
IgG4-positive plasma cells is not yet clear. Whether thesesue by lymphocytes, plasma cells, and eosinophils with stromal
reactive plasma cells according to immunohistochemical study
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represent an epiphenomenon and a diagnostically useful
marker is still not well understood.
In the presenting case, pathologic examination proved
IgG4-related pleuritis and hypophysitis. The imaging study
also revealed mass/nodular lesions in the right lung, para-
spinal region, and bilateral kidneys, and mediastinal lymph
node enlargement, as well as a focal wall thickening of the
stomach. After steroid treatment, the regression of all
lesions was evidenced by image follow-up. Although
a serum IgG4 test was not performed, we suggest the
patient manifested with IgG4-related sclerosing disease,
complicating hypophysitis, pleuritis, multifocal fibro-
sclerosis, lymphadenopathy, zonal tubulointerstitial
nephritis, gastritis, and pulmonary inflammatory
pseudotumor.References
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